Harwood Feffer LLP Announces Investigation of Nutraceutical International Corporation
May 23, 2017
NEW YORK, May 23, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Nutraceutical International Corporation ("Nutraceutical" or the "Company") (NASDAQ: NUTR) concerning the proposed acquisition of the Company by HGGC, LLC ("HGGC").
Under the terms of the offer, HGGC would acquire Nutraceutical in a transaction valued at approximately $446 million. Pursuant to the terms of the transaction, common shareholders of Nutraceutical will receive $41.80 per share in cash.
Our investigation concerns whether the Nutraceutical board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company stockholders.
If you own Nutraceutical shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212) 935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
Attorney Advertising. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP